Product image of Lindynette (Ethinylestradiol, Gestodene) supplied by GNH India

Lindynette

Active Ingredient:
Ethinylestradiol, Gestodene
Origin:
EU

Lindynette (Ethinylestradiol, Gestodene)

Ethinylestradiol, the active ingredient in Lindynette, is a combined oral contraceptive presented as an oral tablet for oral use. It is used to prevent pregnancy and to regulate menstrual cycles in women of reproductive age.

GNH India supplies Lindynette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Lindynette, a combined oral contraceptive, is used to manage hormonal regulation in reproductive health.
  • Contraception: prevents pregnancy by suppressing ovulation and altering cervical mucus.
  • Menstrual cycle regulation: provides more predictable bleeding patterns and reduces menstrual flow.
  • Acne management: can improve hormonal acne by reducing androgen effects on the skin.

How It Works

  • Ethinylestradiol and gestodene act together to suppress the hypothalamic‑pituitary‑gonadal axis, inhibiting the release of luteinising hormone (LH) and follicle‑stimulating hormone (FSH). This prevents follicular development and ovulation. The estrogen component stabilises the endometrial lining, while the progestogen thickens cervical mucus and further alters the endometrium, creating an environment unsuitable for implantation.

Side Effects

Lindynette may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: tension‑type or migraine‑like pain.
  • Breast tenderness: swelling or discomfort.
  • Weight gain: modest increase in fluid retention.
  • Mood changes: irritability or emotional fluctuations.
  • Spotting: irregular bleeding between periods.

Serious or Rare Side Effects

  • Deep vein thrombosis: blood clot formation in deep veins.
  • Pulmonary embolism: clot migration to lung vessels.
  • Stroke: cerebrovascular accident due to clot or hemorrhage.
  • Myocardial infarction: heart attack risk in susceptible individuals.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Liver dysfunction: abnormal liver enzymes or jaundice.

Precautions & Warnings

  • Before prescribing Lindynette, clinicians should evaluate patient‑specific risk factors and provide counseling.
  • Cardiovascular risk assessment: screen for hypertension, clotting disorders, or history of thrombosis.
  • Smoking status review: avoid use in women >35 who smoke heavily.
  • Liver disease evaluation: contraindicated in severe hepatic impairment.
  • Drug interaction check: consider concomitant enzyme‑inducing agents.
  • Missed‑pill counseling: advise on backup contraception if doses are omitted.
  • Store at below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Lindynette can interact with several medicines that affect hormone metabolism or clotting pathways.

Major Interactions (Avoid)

  • Rifampin and other strong enzyme inducers: reduce contraceptive efficacy.
  • Antiretroviral protease inhibitors: may increase hormone levels and risk of side effects.
  • St. John’s wort: accelerates estrogen metabolism, lowering protection.

Moderate Interactions (Monitor Closely)

  • Selective serotonin reuptake inhibitors (SSRIs): may increase bleeding risk.
  • Antihypertensive agents: may enhance blood pressure‑lowering effects.
  • Thyroid hormone replacement: may require dose adjustment of levothyroxine.

Frequently Asked Questions

Lindynette is a combined oral contraceptive containing ethinylestradiol and gestodene. It is prescribed to prevent pregnancy and to help regulate menstrual cycles in women of reproductive age.

The two hormones suppress the hypothalamic‑pituitary‑gonadal axis, blocking the release of luteinising hormone and follicle‑stimulating hormone. This stops ovulation, thickens cervical mucus, and alters the endometrial lining, creating conditions that prevent fertilisation and implantation.

The dosing regimen for Lindynette is determined by the prescribing clinician. Typically, it is taken as a daily oral tablet following the specific cycle schedule indicated on the prescription label.

Lindynette is contraindicated during pregnancy because it is intended to prevent conception. If pregnancy occurs, the medication should be stopped immediately. Limited data are available for breastfeeding; clinicians usually advise caution and may recommend alternative contraception.

To order Lindynette, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lindynette contains gestodene, a third‑generation progestogen, which may offer a lower incidence of androgenic side effects such as acne compared with older progestins. Its efficacy in preventing pregnancy is comparable to other combined oral contraceptives, while the side‑effect profile can differ slightly based on the estrogen‑progestogen combination.

Lindynette tablets should be stored at temperatures below 25 °C, in their original packaging, and protected from moisture and direct sunlight. Do not store in bathrooms or near heat sources, and keep out of reach of children.

Lindynette is taken orally, usually once daily at the same time each day. The tablet is swallowed whole with water and should be started according to the prescribing schedule, often on the first day of the menstrual period.

Serious risks include venous thromboembolism, pulmonary embolism, stroke, myocardial infarction, severe allergic reactions, and liver dysfunction. Patients with a history of clotting disorders, smoking, hypertension, or certain cardiovascular conditions should be evaluated carefully before use.

Lindynette is contraindicated in women who are pregnant, have a known or suspected estrogen‑dependent tumor, have a history of thromboembolic disease, uncontrolled hypertension, severe liver disease, or who are over 35 and smoke heavily. It should also be avoided in individuals with known hypersensitivity to any component of the tablet.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Gestodene

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT